PLEXUS CORP (UK) LIMITED

Company number SC146948 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Credit Assessment: PLEXUS CORP (UK) LIMITED

1. Credit Opinion: CONDITIONAL APPROVAL

Reasoning: The company is a wholly owned subsidiary of a major US multinational (Plexus Corp, NASDAQ: PLXS). Its financial statements show a fundamental reliance on its parent group. While the standalone entity appears small (total assets ~£101k in the filed accounts), the strategic report and notes reveal the company manages substantial turnover, intercompany loans, and operational activities. The core risk is not the standalone balance sheet, but the company's profitability and cash generation at the operational level. The application should be approved strictly on the strength of the parent company guarantee and the strategic importance of this UK entity to the group. Standalone credit metrics are weak and would not support an unsecured facility.

2. Financial Strength

  • Balance Sheet: The filed balance sheet shows shareholders' funds of £55,960k as of Sept 2025. This is a decline from £60,436k in 2024, driven by a reported loss of £5.29m. The company’s net current asset position is not visible in the summary data but is implied to be weak given the increase in net cash cycle days (see below). The primary asset is an intercompany loan balance due from the parent, which provides a direct link to the group’s financial health. The liability side shows minimal external debt, suggesting most financing is intra-group.
  • Profitability: A significant red flag. The company reported a net loss of £5.29m in 2025 (vs. a profit of £17.9m in 2024). The strategic report attributes the loss to a £22.18m drop in dividend income after selling an investment. The underlying operational loss margin has worsened from 6.60% to 6.81%. This indicates the core trading business is unprofitable and becoming more so, despite an 11.5% increase in turnover (£75.5m in 2021 vs likely higher in 2025).
  • Capital Structure: The company has substantial share capital (£3m) and retained earnings, giving it a solvency buffer. However, this buffer is being eroded by ongoing operational losses. The going concern assessment relies on continued parent company support.

3. Cash Flow Assessment

  • Liquidity: The company's cash balance has declined over the last several years, from £38.6k in 2022 to £9.9k in 2025. This is a clear negative trend. The strategic report indicates the company is reliant on the parent for liquidity.
  • Working Capital Management: This is a major area of concern. The strategic report shows a sharp deterioration in working capital efficiency:
    • Debtor Days: Increased from 38 days (2024) to 47 days (2025). This suggests either slower payment or a change in sales mix.
    • Stock Days: Increased from 158 days to 171 days. Excessive stock holding is tying up cash.
    • Creditor Days: Increased from 68 to 78 days. Stretching suppliers could be a sign of cash pressure or a strategic shift.
    • Cash Cycle (Net): Drastically worsened from 33 days (2024) to 71 days (2025). This means the company is now taking over two months longer to convert its inventory and receivables into cash than it did a year ago. This is a significant operational drag and a major risk for a lender.
  • Cash Flow from Operations: Not directly reported, but the loss for the year, combined with a worsening cash cycle, strongly suggests negative operating cash flow. The company is likely consuming cash to fund losses and working capital growth.

4. Monitoring Points

The following key metrics must be tracked, ideally with quarterly or semi-annual management accounts, to ensure the conditional approval remains valid:

  1. Parent Company Guarantee (PCG): The existence and legal validity of the PCG is the single most important monitoring point. Any change in the parent’s financial health (e.g., a rating downgrade, change in debt covenants, or disposal of the UK subsidiary) would trigger an immediate review.
  2. Operational EBITDA/Loss Margin: The worsening trend from -6.60% to -6.81% must reverse. Request a forecast showing a credible path to operational break-even within the next 12-18 months.
  3. Cash Conversion Cycle: The increase from 33 to 71 days in net cash cycle is alarming. Management must commit to a plan to reduce debtor and stock days to at least 2024 levels, ideally better. A failure to improve this metric within 6 months is a serious warning sign.
  4. Intercompany Position: The significant reduction in the intercompany loan (£20.3m to £9.0m) is a positive sign of repayment, but it also reduces the internal liquidity of this entity. Monitor the balance and any future changes.

Perspective: Business Credit Analyst · Model: deepseek/deepseek-v4-flash · Generated 1 October 2026